{
  "documentMetadata": {
    "title": "Pneumonia, Legionella sp.",
    "lastUpdated": "2025-02-10",
    "sourceFile": "Pneumonia, Legionella sp..pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Legionella sp. cause both community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP).",
        "Despite cough, many patients produce small amounts of mucoid non-purulent sputum",
        "Risk factors: Immunocompromised patient, smoking, co-morbidities.",
        "Associated clinical findings (although somewhat nonspecific):",
        "Diarrhea, other gastrointestinal symptoms",
        "Confusion",
        "Relative bradycardia",
        "Hyponatremia",
        "Elevated hepatic enzymes",
        "Elevated BUN and creatinine",
        "Elevated ferritin levels. Range of peak levels: 591-5990 (Clin Infect Dis 46:1789, 2008)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Difficult to detect in culture (need special media). Patient's often do not produce much sputum",
        "Legionella urinary antigen reliable (100% specific) in detection of L. pneumophila, serotype 1, which causes ~80% of the cases in the USA.",
        "Sensitivity 70-80%, hence if urine antigen is negative and clinical suspicion is high, suggest Legionella PCR of respiratory specimen",
        "Legionella PCR of respiratory specimen detects all clinically relevant Legionella species and serotypes",
        "Sensitivity of 0.83-0.98 and specificity of 0.90-0.94 (positive likelihood ratios of 8.3-15, negative likelihood ratios of 0.02-0.2) (J Med Microbiol 2017; 66:485).",
        "Best to test sputum or bronchoalveolar lavage; can use nasopharyngeal swabs but the sensitivity is lower."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Legionella pneumophilia",
        "Other Legionella sp."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Azithromycin",
            "dose": "500 mg",
            "route": "IV/po",
            "frequency": "q24h"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Levofloxacin",
            "dose": "750 mg",
            "route": "IV/po",
            "frequency": "q24h"
          },
          {
            "drug": "Moxifloxacin",
            "dose": "400 mg",
            "route": "IV/po",
            "frequency": "q24",
            "connector": "or"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg",
            "route": "IV/po",
            "frequency": "bid"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Initial intravenous therapy in hospitalized patient with switch to oral once patient has stabilized.",
        "Duration of therapy 7-10 days for immunocompetent host; longer duration (14-21 days) in patients with severe disease or immunocompromised (Clin Chest Med 2017; 38:45-58).",
        "No proven benefit of Rifampin combination therapy (and drug interactions are a major issue in many patients) or combination of Azithromycin + fluoroquinolone"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Macrolides and fluoroquinolones are probably equally effective (Clin Infect Dis 2021;72:1979).",
        "Reference on diagnosis and treatment: Infect Dis Ther. 2022; 11:973-986."
      ]
    }
  ]
}
